[11C]NNC-112

N/A

Report date: 2025/11/25 15:52:53
NME

Base Information

Drug Name[11C]NNC-112
Drug Alias Name[11C]NNC-112
ClassificationRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionDopamine D1 receptor antagonists
TargetsDopamine D1 receptor
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesNational Institute Of Mental Health (Nimh)
Active IndicationsDiagnostic agents
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A